<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02775877</url>
  </required_header>
  <id_info>
    <org_study_id>HL2015</org_study_id>
    <nct_id>NCT02775877</nct_id>
  </id_info>
  <brief_title>Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer</brief_title>
  <official_title>Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer in Polycystic Ovary Syndrome (PCOS) Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Navy General Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Navy General Hospital, Beijing</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the effects of letrozole and sequential clomiphene in
      ovulation and pregnancy in PCOS patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the efficacy of letrozole and clomiphene in PCOS patients is important,especially
      in resistent PCOS patients. Although most medications prove the effectiveness of letrozole
      and clomiphene,the subjects of letrozole and sequential clomiphene in PCOS patients are
      rarely.The trial may provide further basis for this medication in PCOS patients in ovulation.
      If the medication demonstrates efficacy, the method would help the patients with PCOS to deal
      with the problem of infertility.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>live birth rate</measure>
    <time_frame>3 years</time_frame>
    <description>The event that a FETUS is born alive with heartbeats or RESPIRATION</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical pregnancy rate</measure>
    <time_frame>3 years</time_frame>
    <description>The ratio of the number of conceptions (CONCEPTION) including Live BIRTH; STILLBIRTH; and fetal losses, to the mean number of females of reproductive age in a population during a set time period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>multiple pregnancies</measure>
    <time_frame>3 years</time_frame>
    <description>The condition of carrying two or more FETUSES.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>miscarriage</measure>
    <time_frame>3 years</time_frame>
    <description>Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mature follic</measure>
    <time_frame>1 month</time_frame>
    <description>The diameter of follic more than 18mm is the mature follic</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Female Infertility Due to Nonimplantation of Ovum</condition>
  <arm_group>
    <arm_group_label>letrozole and clomiphene</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Letrozole 5 mg tablet orally from 3-7 day of once a day menstrual cycle and clomiphene100 mg tablet orally once a day from 11-15 day of menstrual cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Letrozole and human menopausal gonadotropin (HMG)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Letrozole 5 mg tablet orally from 3-7 day of once a day menstrual cycle and HMG 75u once a day by intramuscular injection from 11-15day of menstrual cycle</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Letrozole</intervention_name>
    <arm_group_label>letrozole and clomiphene</arm_group_label>
    <arm_group_label>Letrozole and human menopausal gonadotropin (HMG)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>clomiphene</intervention_name>
    <arm_group_label>letrozole and clomiphene</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HMG</intervention_name>
    <arm_group_label>Letrozole and human menopausal gonadotropin (HMG)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with PCOS

        Exclusion Criteria:

          -  â€¢Women more than 38 years or less than 20 years

               -  With infectious diseases or endocrine diseases

               -  Who refuse to participate in the experiment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aiming Wang, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Navy General Hospital, Beijing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li He</last_name>
    <phone>17710379833</phone>
    <email>qiufengyi0505@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology, Navy General Hospital.</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100048</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunhai Chuai, Dr</last_name>
      <phone>+8618810892004</phone>
      <email>wangyh85@foxmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Aiming Wang, Dr</last_name>
      <phone>+8618600310258</phone>
      <email>one_army@sina.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Kamath MS, George K. Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate. Reprod Biol Endocrinol. 2011 Jun 21;9:86. doi: 10.1186/1477-7827-9-86.</citation>
    <PMID>21693034</PMID>
  </reference>
  <reference>
    <citation>Legro RS, Kunselman AR, Brzyski RG, Casson PR, Diamond MP, Schlaff WD, Christman GM, Coutifaris C, Taylor HS, Eisenberg E, Santoro N, Zhang H; NICHD Reproductive Medicine Network. The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome. Contemp Clin Trials. 2012 May;33(3):470-81. doi: 10.1016/j.cct.2011.12.005. Epub 2012 Jan 13.</citation>
    <PMID>22265923</PMID>
  </reference>
  <results_reference>
    <citation>Hajishafiha M, Dehghan M, Kiarang N, Sadegh-Asadi N, Shayegh SN, Ghasemi-Rad M. Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome. Drug Des Devel Ther. 2013 Dec 3;7:1427-31. doi: 10.2147/DDDT.S50972. eCollection 2013. Erratum in: Drug Des Devel Ther. 2017 Apr 28;11:1367.</citation>
    <PMID>24348019</PMID>
  </results_reference>
  <results_reference>
    <citation>Legro RS, Zhang H; Eunice Kennedy Shriver NICHD Reproductive Medicine Network. Letrozole or clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014 Oct 9;371(15):1463-4. doi: 10.1056/NEJMc1409550.</citation>
    <PMID>25295506</PMID>
  </results_reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2015</study_first_submitted>
  <study_first_submitted_qc>May 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2016</study_first_posted>
  <last_update_submitted>June 21, 2017</last_update_submitted>
  <last_update_submitted_qc>June 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Navy General Hospital, Beijing</investigator_affiliation>
    <investigator_full_name>Yunhai Chuai</investigator_full_name>
    <investigator_title>Department of Obstetrics and Gynecology, Navy General Hospital, Beijing</investigator_title>
  </responsible_party>
  <keyword>PCOS</keyword>
  <keyword>letrozole</keyword>
  <keyword>clomiphene</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Letrozole</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

